The pharmaceutical and biological industry has a net outflow of 2.855 billion yuan today, and the net outflow of 6 shares exceeds 100 million yuan. Post date May 13, 2022 — 19:02 Post Lock Read More Bairen Medical (688198): Legal Opinion of Shanghai Junlan Law Firm on the 2021 Annual General Meeting of Beijing Bairen Medical Technology Co., Ltd. CFi.CN Post date May 12, 2022 — 20:12 Post Lock Read More The average share price of the Science and Technology Innovation Board is 30.40 yuan, and the share price of 8 shares exceeds 300 yuan_Oriental Fortune Net Post date May 10, 2022 — 18:53 Post Lock Read More The average share price of the Science and Technology Innovation Board is 30.40 yuan, and the share price of 8 shares exceeds 300 yuan. Post date May 10, 2022 — 18:53 Post Lock Read More GF Shengjin Mixed A Net Worth Up 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More GF Shengjin's mixed C net worth rose 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More The 100 yuan shares of the Science and Technology Innovation Board reached 55 Hemai shares with the highest share price_Oriental Fortune Net Post date April 29, 2022 — 18:42 Post Lock Read More The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance Post date April 28, 2022 — 11:27 Post Lock Read More GF Shengjin's mixed C net worth rose 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Bairen Medical (688198): Legal Opinion of Shanghai Junlan Law Firm on the 2021 Annual General Meeting of Beijing Bairen Medical Technology Co., Ltd. CFi.CN Post date May 12, 2022 — 20:12 Post Lock Read More The average share price of the Science and Technology Innovation Board is 30.40 yuan, and the share price of 8 shares exceeds 300 yuan_Oriental Fortune Net Post date May 10, 2022 — 18:53 Post Lock Read More The average share price of the Science and Technology Innovation Board is 30.40 yuan, and the share price of 8 shares exceeds 300 yuan. Post date May 10, 2022 — 18:53 Post Lock Read More GF Shengjin Mixed A Net Worth Up 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More GF Shengjin's mixed C net worth rose 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More The 100 yuan shares of the Science and Technology Innovation Board reached 55 Hemai shares with the highest share price_Oriental Fortune Net Post date April 29, 2022 — 18:42 Post Lock Read More The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance Post date April 28, 2022 — 11:27 Post Lock Read More GF Shengjin's mixed C net worth rose 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The average share price of the Science and Technology Innovation Board is 30.40 yuan, and the share price of 8 shares exceeds 300 yuan_Oriental Fortune Net Post date May 10, 2022 — 18:53 Post Lock Read More The average share price of the Science and Technology Innovation Board is 30.40 yuan, and the share price of 8 shares exceeds 300 yuan. Post date May 10, 2022 — 18:53 Post Lock Read More GF Shengjin Mixed A Net Worth Up 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More GF Shengjin's mixed C net worth rose 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More The 100 yuan shares of the Science and Technology Innovation Board reached 55 Hemai shares with the highest share price_Oriental Fortune Net Post date April 29, 2022 — 18:42 Post Lock Read More The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance Post date April 28, 2022 — 11:27 Post Lock Read More GF Shengjin's mixed C net worth rose 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The average share price of the Science and Technology Innovation Board is 30.40 yuan, and the share price of 8 shares exceeds 300 yuan. Post date May 10, 2022 — 18:53 Post Lock Read More GF Shengjin Mixed A Net Worth Up 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More GF Shengjin's mixed C net worth rose 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More The 100 yuan shares of the Science and Technology Innovation Board reached 55 Hemai shares with the highest share price_Oriental Fortune Net Post date April 29, 2022 — 18:42 Post Lock Read More The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance Post date April 28, 2022 — 11:27 Post Lock Read More GF Shengjin's mixed C net worth rose 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
GF Shengjin Mixed A Net Worth Up 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More GF Shengjin's mixed C net worth rose 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More The 100 yuan shares of the Science and Technology Innovation Board reached 55 Hemai shares with the highest share price_Oriental Fortune Net Post date April 29, 2022 — 18:42 Post Lock Read More The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance Post date April 28, 2022 — 11:27 Post Lock Read More GF Shengjin's mixed C net worth rose 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
GF Shengjin's mixed C net worth rose 5.20% Post date April 30, 2022 — 09:33 Post Lock Read More The 100 yuan shares of the Science and Technology Innovation Board reached 55 Hemai shares with the highest share price_Oriental Fortune Net Post date April 29, 2022 — 18:42 Post Lock Read More The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance Post date April 28, 2022 — 11:27 Post Lock Read More GF Shengjin's mixed C net worth rose 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The 100 yuan shares of the Science and Technology Innovation Board reached 55 Hemai shares with the highest share price_Oriental Fortune Net Post date April 29, 2022 — 18:42 Post Lock Read More The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance Post date April 28, 2022 — 11:27 Post Lock Read More GF Shengjin's mixed C net worth rose 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance Post date April 28, 2022 — 11:27 Post Lock Read More GF Shengjin's mixed C net worth rose 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
GF Shengjin's mixed C net worth rose 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
GF Shengjin Mixed A Net Worth Up 4.46% Post date April 28, 2022 — 09:39 Post Lock Read More Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Bairen Medical (688198.SH) plans to pay 5 yuan per 10 to 4 distributions in 2021 Post date April 26, 2022 — 20:37 Post Lock Read More Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ranking of high-priced stocks on the Science and Technology Innovation Board Post date April 26, 2022 — 19:01 Post Lock Read More Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuanda Healthy Life Mixed A Net Worth Down 3.91% Post date April 26, 2022 — 07:06 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Orient Securities maintains Bairen Medical's buy rating: ophthalmic bio-patches have completed research and development and gradually entered the harvest period. The target price is 207.59 yuan. Post date April 25, 2022 — 11:46 Post Lock Read More Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang Post date April 25, 2022 — 11:42 Post Lock Read More Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Bairen Medical's net profit in the first quarter of 2022 was 13.6069 million, an increase of 53.54% year-on-year, and share-based payment expenses decreased year-on-year. Post date April 24, 2022 — 23:51 Post Lock Read More Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Orient Securities gives Bairen Medical a buy rating: R&D progresses in great strides, and performance continues to maintain rapid growth Post date April 22, 2022 — 15:21 Post Lock Read More Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Orient Securities gave Bairen Medical a Buy rating: R&D progressed with great strides and performance continued to maintain rapid growth – yqqlm Post date April 22, 2022 — 15:21 Post Lock Read More 1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
1904 companies announce annual dividend plans_ Securities Times Network Post date April 22, 2022 — 10:19 Post Lock Read More GF Shengjin's mixed C net worth fell 3.67% Post date April 22, 2022 — 09:13 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!